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Patient and technique survival on peritoneal dialysis in the
United States: Evaluation in large incident cohorts. Secular
trends in dialysis require a frequent re-examination of outcomes
in patients on renal replacement modalities. We examined three
large cohorts of patients initiating peritoneal dialysis (PD) in
1999, 2000, and 2001 (total of >30,000 patients) to ascertain
trends in patient outcomes, technique success, and predictors
of both parameters of interest. Trends toward improved patient
survival, higher technique success, and increasing use of cycler-
based therapy, with more recent calendar years were noted.
Age and diabetes were clear predictors of patient survival, but
did not appear to influence technique success. Technique suc-
cess was higher in patients on automated PD (APD) than in
patients on continuous ambulatory PD (CAPD), but this dif-
ference was mostly concentrated in the first year on therapy.
Patients starting PD after a failed allograft had excellent sur-
vival. We conclude that the current state of PD in the United
States is characterized by improving patient outcomes, higher
technique success, and a predominance of use of cycler-based
therapy. Several opportunities for improving technique success
amenable to practice interventions have been identified. The
high success of PD in patients with failed allograft suggests that
it is beneficial to utilize this modality more frequently in this
patient group than current practice.
INTRODUCTION
Dialysis care is a dynamic process subject to the in-
fluence of advances in clinical processes and technologic
innovations. Secular trends in this process help elucidate
successes as well as opportunities for practice modifica-
tions or areas in need of iterative technical innovations.
Evaluations of these trends can derive from multiple
sources. National and regional registries have offered
valuable insights into the survival of patients on vari-
ous dialytic modalities and rates of modality transfers
[1–9]. These studies are limited, however, in the area
of causations of modality transfer and on the impact
of submodality utilization [automated peritoneal dialy-
sis (APD) vs. continuous ambulatory peritoneal dialysis
(CAPD)]. Single-center studies have been valuable in the
Key words: continuous ambulatory peritoneal dialysis, end-stage renal
disease, hemodialysis.
C© 2003 by the International Society of Nephrology
degree of detail they offer, but generalizations from these
studies are limited as they represent a distinct locale and
practice group and are, thus, subject to biases of center
effect [8, 10–31].
Both national and single-center studies can also be lim-
ited in their timeliness and the interval between data ac-
quisition and final analysis leading to publication. It is in-
tuitively obvious that data relating to cohorts of patients
of several years past may be valuable but not uniformly
pertinent to modern practice. Regrettably, such outdated
data from national registries [32] have in the past im-
pacted views of modality choices and the prestige of a
large registry has often obscured glaring shortcomings.
Similarly, single-center studies tend to telescope infor-
mation over several years (sometimes decades) to obtain
a sample size suitable for meaningful analysis [17, 19, 20,
22, 29, 33]. An approach that can bridge the advantages
of both types of evaluations and yet bypass the limita-
tions of lack of timeliness and generalization would be
valuable in elucidating the trends in dialytic therapy, par-
ticularly in the context of identifying areas of success that
validate certain clinical approaches and areas of oppor-
tunities for practice modification. The present analysis
was undertaken to provide insight into the status of pa-
tient and technique survival in contemporary cohorts of
patients on peritoneal dialysis (PD) in the United States.
METHODS
The present analysis is based on three cohorts of United
States patients that started peritoneal dialysis in the years
1999, 2000, and 2001 and were followed until Febru-
ary of 2003. Information about these patients is tracked
in the Baxter Healthcare Corporation On-CallTM sys-
tem, which tracks in a Health Insurance Portability and
Accountability Act (HIPAA)-compliant approach stan-
dard demographics, treatment history for renal disease
(new to dialysis vs. transfer from hemodialysis or failed
allograft), transfer from PD to hemodialysis (HD) (in-
cluding causes) or transplant, patient outcome, and gen-
eral details of dialytic therapy, such as submodality use
(CAPD vs. APD) and overall dialysis prescription. This
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Table 1. Examples of causes of modality transfer captured by the
system
Peritonitis
Catheter infection: tunnel and/or exit site infection
Catheter problem: leaks, obstruction, migration, malfunction
Inadequate dialysis: inadequate clearance, not meeting
Kt/V and/or CrCl targets, membrane failure
Ultrafiltration failure: inability to maintain target
weight and edema-free
Other medical
Inadequate dietary intake/albumin loss
Respiratory problems
Cardiac complications
Diabetic complications
Hernia
Abdominal surgeries
Gained or lost too much weight (not fluid related)
Psychologic
Social: insufficient support (family or nurse), transferred
to nursing home
information is gathered as a component of the home de-
livery system of dialysis supplies and, hence, has the dis-
tinct advantage of reflecting actual rather than reported
conditions. De-identified information from this system
forms the basis of this analysis.
A detailed list of possible causes of transfer is main-
tained within the system to allow for categorization of
primary causes of modality transfer (Table 1). All events
within this system are dated; therefore, potential trends of
interest can be examined and time windows of event oc-
currences can be determined. Transfer to HD rate was
defined as the number of patients transferred to HD
in a particular year divided by the total number of pa-
tients starting that year. Transplant rate was defined as
the number of patients transplanted within a particular
year divided by the total number of patients starting that
year.
For this analysis, causes of transfer were grouped in
broad categories as follows: infection (peritonitis and
catheter infection), catheter problem, inadequate dial-
ysis, ultrafiltration failure/fluid management issues, psy-
chosocial causes, and other medical causes. Psychosocial
causes included psychologic and social/learning, as de-
fined in Table 1.
Kaplan-Meier method was used to analyze actuarial
patient and technique survival. Data were censored at the
following events: switch to HD, transplantation, death,
loss to follow-up, recovery of native renal function, with
the exception of death for patient survival calculation,
and the exception of switch to HD for technique survival
calculation.
Cox regression estimation was performed for patient
and technique survival in order to take into account the
relative effects of various risk factors. In the current anal-
ysis, adjustments for age, diabetic status, gender, cen-
ter size, calendar year, and PD submodality (APD vs.
CAPD) were performed where appropriate.
Table 2. General demographics of the three study cohorts
Year 1999 2000 2001
Total 11,137 10,658 10,340
Male:female % 52:48 53:47 52:48
DM:non-DM % 42:58 45:55 44:56
APD:CAPD % 59:41 63:37 66:34
Age 53.3 ± 19.1 54.2 ± 18.1 54.8 ± 18.1
New to dialysis 8081 7665 7457
Male:female % 52:48 54:46 52:48
DM:non-DM % 43:57 45:55 44:56
APD:CAPD % 59:41 64:36 66:34
Age 53.4 ± 19.7 54.5 ± 18.9 55.4 ± 18.8
Transfer from HD 2846 2828 2704
Male:female % 52:48 53:47 53:47
DM:non-DM % 41:59 45:55 45:55
APD:CAPD % 59:41 63:37 65:35
Age 54.1 ± 16.8 54.7 ± 16.1 55.6 ± 16.6
Failed transplant 210 165 179
Male:female % 41:59 48:52 45:55
DM:non-DM % 23:77 22:78 27:73
APD:CAPD % 63:37 64:36 68:32
Age 34.2 ± 18.5 40.2 ± 14.5 39.3 ± 15.1
Abbreviations are: APD, automated peritoneal dialysis; CAPD, continuous
ambulatory peritoneal dialysis; DM, diabetes mellitus.
RESULTS
General characteristics of the population
The overall profile of the study populations is shown in
Table 2. The majority of patients starting PD in any of the
three calendar years were new to dialysis (71%–73%).
However, a substantial proportion of patients (25%–
27%) were transferred from HD. Patients with a failed
allograft accounted for a small percentage of all patients
(1%–2%). In all three cohorts, a slight preponderance of
males was observed for patients new to dialysis and trans-
ferred from HD. The opposite was true of patients with
a failed allograft. Patients transferred from HD had a
similar profile as patients new to dialysis in terms of age,
gender distribution, diabetes prevalence, and choice of
APD vs. CAPD. Patients with a failed allograft were gen-
erally younger than the other two groups of patients (new
to dialysis and transferred from HD, P < 0.0001), had
a slight preponderance of females, a significantly lower
prevalence of diabetes, and a higher rate of choosing APD
vs. CAPD than the other two groups (Table 2). The dis-
tribution of patients across the age spectrum is shown
in Figure 1. This distribution approached a bell-shaped
curve in contrast with the distribution of all incident pa-
tients to dialysis from the United States Renal Data Sys-
tem (USRDS), which was skewed to the right with a
preponderance of older patients. The two genders were
equally distributed in all age categories except for sub-
jects above age 70, where males were over-represented
(M:F, 60:40).
Diabetics (DM) were older than non-diabetics (non-
DM) in all three cohorts: in the 1999 cohort, the average
age of DM was 57.4 ± 13.7 vs. 50.6 ± 21.3 years in the
non-DM group (P < 0.0001); in the 2000 cohort, it was
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Fig. 1. Age distribution of all patients in the three cohorts compared
to data from the USRDS on new patients entering dialysis.
57.8 ± 13.8 in DM vs. 51.2 ± 20.4 years in non-DM
(P < 0.0001); and in the 2001 cohort, DM 58.5 ± 13.4 vs.
non-DM 51.8 ± 20.6 years (P < 0.0001). The same was
also true in every subset of patients of different ESRD
treatment history within each cohort (i.e., diabetics were
also older than non-diabetics among patients new to dial-
ysis, transferred from hemodialysis, and with failed renal
allograft).
A high proportion of patients starting PD in any of
the calendar years selected APD as their submodality
of choice with a trend toward increasing APD choice,
even within the three-year period of observation (59%–
66%), suggesting that cycler-based therapy is becoming
the dominant mode of peritoneal dialysis in the United
States. The proportion of patients on APD was over 60%
in all age groups except for those over 80 years, where
slightly more than 40% were still on CAPD, a surpris-
ing finding considering the logistic simplification of the
therapy afforded by cycler use. The sedentary lifestyle in
this age category may explain the persistence of higher
CAPD use.
Survival by patient characteristics
The survival of patients in the three cohorts at vari-
ous time intervals is illustrated in Table 3. Patients new
to dialysis had a slightly higher survival than that of pa-
tients transferred from HD. The survival difference was
statistically significant at P < 0.0001 for the years 1999
and 2000, and P < 0.05 for year 2001. Although the two
groups had similar mean age, duration with end-stage re-
nal disease (ESRD) may play a role in this difference.
In both groups, a trend toward improved survival in the
more recent cohort was apparent (Table 3) despite no
change in age or the prevalence of diabetes (Table 2)
(P < 0.0001).
The highest survival at any time interval in all three co-
horts was in patients with failed renal allograft. This may
be related to the fact that these patients were generally
younger than patients new to dialysis or transferring from
Table 3. Patient survival (%) trends in the three study cohorts
Year 1999 2000 2001
Total
One year 82.47 ± 0.40 84.10 ± 0.39 86.19 ± 0.38
Two year 69.22 ± 0.54 72.12 ± 0.54
Three year 57.94 ± 0.65
New to dialysis
One year 83.12 ± 0.46 84.69 ± 0.45 86.72 ± 0.43
Two year 69.94 ± 0.63 72.9 ± 0.63
Three year 58.12 ± 0.77
Transfer from HD
One year 79.87 ± 0.84 81.91 ± 0.81 85.04 ± 0.71
Two year 66.07 ± 1.10 68.94 ± 1.07
Three year 56.00 ± 1.28
Failed transplant
One year 91.42 ± 2.14 88.99 ± 2.81 89.08 ± 2.61
Two year 82.71 ± 3.18 85.22 ± 3.43
Three year 74.65 ± 4.08
HD, hemodialysis.
Table 4. First-year patient survival (%) in the pooled cohorts by age,
diabetic status, and modality use
First-year P for
Comparison survival CI comparison
Age
<55 years 85.84 85.36–86.33 P < 0.001
>55 years 78.95 77.92–79.97
Comorbidity
Diabetic 81.13 80.35–81.92 P < 0.001
Non-diabetic 87.03 86.45–87.62
Modality
CAPD 78.48 77.62–79.33 P < 0.001
APD 87.24 86.74–87.74
Combinations
Diabetic CAPD 74.82 73.35–76.29 P < 0.001
Non-diabetic CAPD 82.23 81.08–83.38
Diabetic APD 84.60 83.70–85.50 P < 0.001
Non-diabetic APD 89.54 88.88–90.20
<55 years
Diabetic CAPD 75.93 74.23–77.64 P < 0.001
Non-diabetic CAPD 84.27 83.03–85.50
Diabetic APD 86.64 85.62–87.66 P < 0.001
Non-diabetic APD 90.80 90.10–91.50
>55 years
Diabetic CAPD 71.87 68.97–74.78 P < 0.001
Non-diabetic CAPD 75.00 72.19–77.80
Diabetic APD 79.99 78.19–81.79 P < 0.001
Non-diabetic APD 84.76 83.06–86.46
APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal
dialysis.
HD. These patients, however, might have had a longer du-
ration with ESRD and been subjected to a longer period
of enhanced cardiovascular risk. Nevertheless, they did
display the best survival.
To gain insight into the determinants of patient sur-
vival, various comparisons were performed using the
Kaplan-Meier estimator for one-year patient survival ap-
plied to a pooled database inclusive of all three cohorts
(Table 4). Age was clearly a determinant of survival.
Diabetic patients tended to have a worse survival than
non-diabetic patients. Because of a modality effect on
outcomes (vide infra), a combination of group defini-
tion by age grouping, diabetic status, and modality was
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Table 5. Mean age of patients on APD and CAPD by diabetic status
APD CAPD
Year All Diabetic Non-diabetic All Diabetic Non-diabetic
1999 51.7 ± 20.5 57.7 ± 13.1 48.0 ± 22.9 55.7 ± 16.4 56.9 ± 14.5 54.9 ± 17.6
2000 53.1 ± 18.8 57.7 ± 13.7 49.5 ± 21.3 56.2 ± 16.7 58.0 ± 14.1 54.1 ± 18.4
2001 53.8 ± 18.9 58.3 ± 13.2 50.1 ± 21.5 56.8 ± 16.4 58.9 ± 13.8 55.1 ± 18.1
APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis.
undertaken and the results presented in the next section.
The effects of age and diabetes on outcome were signifi-
cant in all combinations (Table 4).
Patient survival by modality
The unadjusted Kaplan-Meier estimates showed that
CAPD patients tended to have a worse survival than APD
patients (Table 4). Since CAPD patients overall tended
to be older than APD patients in all three patient cohorts
(Table 5), adjustments for the effects of age and diabetic
status were undertaken. On closer examination, the age
differential between CAPD and APD tended to be more
prominent among non-diabetic patients (Table 5); hence,
comparisons of outcomes in the two modalities were un-
dertaken by diabetic status with and without adjustment
for age (Table 4). The difference in mortality between
CAPD and APD was observed for the group overall
(P < 0.0001) and with adjustment for diabetic status
(P < 0.0001). Similar differences were found when the
comparisons were done in patients younger than 55 years
and diabetic (P < 0.001), younger than 55 years and non-
diabetic (P < 0.0001), older than 55 years and diabetic
(P < 0.0001), and older than 55 years and non-diabetic
(P < 0.0001). These directional changes were confirmed
using Cox regression analysis adjusted for age and
diabetic status.
Technique success by patient characteristics
Transfer to hemodialysis was similar among patients
who were new to dialysis, having originally transferred
from hemodialysis, or with a failed allograft (Table 6).
There was a trend of decreased transfer to HD, with
this effect being predominantly more noticeable in pa-
tients new to dialysis with the more recent cohorts
(P < 0.0001). In patients both new to dialysis and pa-
tients transferred from HD, transfer to HD rate was usu-
ally higher in the first than in subsequent years on PD
(Table 6) (P = 0.0001).
To gain insight into the determinants of technique
success, various comparisons were performed using the
Kaplan-Meier estimator for one-year technique success
applied to a pooled database inclusive of all three co-
horts (Table 7). Age was not a determinant of technique
success, and patients older than 55 years had similar tech-
nique success as patients younger than 55 years. Diabetic
Table 6. Rates of transfer to HD in the three study cohorts
Year 1999 2000 2001
Total
One year 20.51 19.75 18.65
Two year 16.51 17.58
Three year 16.09
New to dialysis
One year 19.60 18.29 17.20
Two year 16.13 17.16
Three year 15.75
Transfer from HD
One year 23.12 23.51 21.96
Two year 17.33 19.03
Three year 17.61
Failed transplant
One year 17.61 23.03 16.75
Two year 21.37 18.68
Three year 12.34
APD, automated peritoneal dialysis; CAPD, continuous ambulatory
peritoneal dialysis; HD, hemodialysis.
Table 7. First-year technique success (%) in the pooled cohorts by
age, diabetic status, and modality use
First-year P for
Comparison success CI comparison
Age
<55 years 77.39 76.83–77.96 NS
>55 years 75.31 74.24–76.37
Comorbidity
Diabetic 75.45 74.61–76.29 P < 0.001
Non-diabetic 78.06 77.36–78.77
Modality
CAPD 68.81 67.88–69.74 P < 0.001
APD 81.30 80.72–81.87
Combinations
Diabetic CAPD 67.63 66.10–69.16 P < 0.05
Non-diabetic CAPD 69.87 68.55–71.20
Diabetic APD 79.91 78.93–80.89 P < 0.001
Non-diabetic APD 82.41 81.61–83.21
<55 years
Diabetic CAPD 67.43 65.64–69.22 P < 0.05
Non-diabetic CAPD 70.87 69.39–72.36
Diabetic APD 80.55 79.39–81.71 P < 0.001
Non-diabetic APD 82.51 81.61–83.40
>55 years
Diabetic CAPD 68.19 65.27–71.12 NS
Non-diabetic CAPD 66.28 63.34–69.22
Diabetic APD 78.41 76.57–80.25 P < 0.05
Non-diabetic APD 82.03 80.25–83.81
APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal
dialysis.
patients tended to have a slightly lower technique suc-
cess than non-diabetic patients. The difference did attain
statistical significance because of the large size of the com-
bined patient cohort (>30,000 patients). The confidence
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Fig. 2. Proportions of patients in the 2000 cohort who transferred to
hemodialysis during the first year on peritoneal dialysis (PD) by causes
of transfer.
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Fig. 3. Proportions of patients in the 2000 cohort in the three patient
categories who transferred to hemodialysis during the first year on peri-
toneal dialysis (PD) by the most common causes of transfer.
intervals for the diabetic and non-diabetic patients were
so close as to preclude any real clinical relevance to the
statistical finding.
The proportional contributions of various causes to
transfer to HD were similar across all three inception
cohorts and, hence, will be illustrated for only the mid-
dle cohort (year 2000). The highest causes of transfer to
HD in the first year on PD for all patients were infec-
tion (peritonitis and catheter-related), catheter malfunc-
tion, and inadequate dialysis (Fig. 2). When examined
by type of patient (Fig. 3), subjects coming to PD with
a failed allograft were more likely than the other two
groups to transfer to HD because of infection; the dif-
ference, however, was significant (P = 0.05) only when
compared to patients new to dialysis. No significant dif-
ferences were observed between groups for catheter mal-
function as a cause of transfer to HD, inadequate dialysis,
or other medical causes. Psychosocial causes were similar
among patients new to dialysis and patients transferred
from HD but tended to be lower for patients with a failed
allograft. The younger age of these patients may have
been a contributory factor to this difference. No differ-
ence in the role of infection as a cause of transfer to HD
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Fig. 4. Proportions of patients in the 2000 cohort in the three patient
categories who transferred to hemodialysis during the first year on peri-
toneal dialysis (PD) because of infection by diabetic status.
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Fig. 5. Time trends in the proportions of patients in the three cohorts
and in the three patient categories who transferred to hemodialysis
during the first year on peritoneal dialysis (PD) because of infection.
was observed between diabetic and non-diabetic patients
(Fig. 4). It should be noted here that this similarity per-
tains to infection as a cause of transfer and not to the
prevalence of infection, per se, which was not evaluated
in this study.
Examination of the time trends in causes of transfer to
HD during the first year on PD suggested that no signif-
icant changes in proportional causations were observed
among the three cohorts (1999, 2000, 2001), except for
a tendency for infection as a cause of transfer to mani-
fest a progressive decline (P < 0.0001) (Fig. 5). Within
each of the 1999 and 2000 cohorts, a tendency for both
catheter malfunction and psychosocial causes for trans-
fer to HD to decline from the first to the second year
on PD was noted (Fig. 6) (P = 0.05). The time trend for
both catheter malfunction and psychosocial was marked
among patients on CAPD and less evident among pa-
tients on APD (CAPD catheter malfunction, 1999 year
one, 5.36%; year two, 3.30%; 2000 year one, 5.74%; year
two, 2.34%. APD catheter malfunction, 1999 year one,
3.71%; year two, 2.97%; 2000 year one, 3.36%; year two,
2.82%) (CAPD psychosocial, 1999 year one, 3.24%; year
two, 1.00%; 2000 year one, 3.80%; year two, 2.06%. APD
psychosocial, 1999 year one, 2.11%; year two, 1.40%;
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Fig. 6. Time trends in the proportions of patients in the 1999 and 2000
cohorts who transferred to hemodialysis during the first and second
years on peritoneal dialysis (PD) because of catheter malfunction and
psychosocial causes.
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Fig. 7. Proportions of patients in the 2000 cohort who transferred to
hemodialysis during the first year on peritoneal dialysis (PD) by sub-
modality [continuous ambulatory peritoneal dialysis (CAPD) vs. auto-
mated peritoneal dialysis (APD)]. (CAPD vs. APD).
2000 year one, 1.89%; year two, 1.78%) (P = 0.05 for
CAPD). This suggests that catheter malfunction usually
manifests early in the course of peritoneal dialysis and
that psychosocial causes are not always the results of cu-
mulative time-burden, but may reflect adaptation to the
logistics of the therapy. These time trends suggest that at-
tention to catheter insertion techniques and support for
CAPD patients in the early phases of therapy are crucial
toward enhancing therapy success.
Technique success by modality
Transfer to HD was lower in patients on APD than in
patients on CAPD overall and in each category of trans-
fer causes (Fig. 7) (P < 0.0001). This differential was most
evident in the first year on PD and tended to disappear
during the second year of therapy (Fig. 8). Closer exam-
ination of the transfer curves suggested that the rate of
transfer in CAPD patients was highest during the first six
months of therapy and tended to stabilize beyond that
point. The time period prior to the inflection point can
thus be viewed as a period of vulnerability to technique
CAPD APD
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Fig. 8. Proportions of patients in the 2000 cohort who transferred to
hemodialysis during the second year on peritoneal dialysis (PD) by
submodality [continuous ambulatory peritoneal dialysis (CAPD) vs.
automated peritoneal dialysis (APD)].
failure and may need to become a focus of interventional
scrutiny.
Within each modality, age continued to have no effect
when patients were stratified by age and diabetes, except
in the non-diabetic CAPD group, where it had a marginal
effect (Table 7). The effect of diabetes was also very small
within modalities, whether or not they were stratified by
age in addition to modality and diabetes (Table 7). CAPD
patients tended to have a lower technique success than
APD patients (Table 7). The difference in technique suc-
cess between CAPD and APD was observed when CAPD
outcomes were compared to APD for the group overall
(P < 0.0001), with adjustment for diabetic status (P <
0.0001), and when the comparisons were done in patients
younger than 55 years and diabetic (P < 0.001), younger
than 55 years and non-diabetic (P < 0.0001), older than
55 years and diabetic (P < 0.0001), and older than 55 years
and non-diabetic (P < 0.0001). In a multivariate analy-
sis that controlled for the effects of age, diabetes, gender,
and patient origin (new to dialysis, transfer from HD, and
failed allograft), the use of CAPD was associated with a
higher rate of technique failure than APD (hazard ratio,
1.583, P = 0.0001). In the same analysis, gender and pa-
tient origin were found to have no effect on technique
success.
The effects of center size (<20 patients vs. >20 pa-
tients) on technique success were examined in a multi-
variate analysis that controlled for the effects of diabetes,
gender, PD sub-modality (CAPD vs. APD), and patient
origin (new to dialysis, transfer from HD, and failed allo-
graft) and applied to the combined three inception co-
horts. Centers with less than 20 patients had a higher
rate of technique failure than centers with more than
20 patients (hazard ratio, 1.130, P < 0.0001).
Transplantation by patient characteristics
In patients both new to dialysis and patients transfer-
ring from HD, transplantation was usually lower in the
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first than in subsequent years on PD (Table 8) in all three
inception cohorts. Patients who started PD because of a
failed allograft had a greater chance of being transplanted
than either patients new to dialysis or those transferred
from HD. This tendency for higher transplant rate was
likely related to the lower age.
The effects of age, diabetes, gender, PD modality, and
patient origin (new to dialysis, transfer from HD, and
failed allograft) on transplant rate were examined in
a multivariate analysis applied to the combined three
inception cohorts. Older age (hazard ratio, 0.966, P <
0.0001), diabetic versus nondiabetic status (hazard ratio,
0.873, P = 0.028), male versus female gender (hazard ra-
tio, 1.30, P < 0.0001), and CAPD versus APD modality
(hazard ratio, 1.32, P < 0.0001) were all independently
associated with effects on transplantation rate. The pa-
tient origin had no influence on rate of transplant in this
multivariate model. Patients who started PD because of
a failed allograft no longer had a greater chance of being
transplanted than either patients new to dialysis or those
transferred from HD.
DISCUSSION
The present study examined the profile of PD practice
in the United States in three large inception cohorts of
patients who started PD in the years 1999, 2000, and 2001.
These large cohorts have allowed us to gain insight into
the practice patterns, as well as the patient and technique
outcomes in contemporary patient populations. The find-
ings of this study will be discussed under several general
headings: the characterization of the population on PD
in general; determinants of patient survival; factors influ-
encing technique success; and the rates of transplantation
in this population.
The demographic characteristics of the patient popula-
tion in the present study are similar to those of the dialysis
population in the United States in general and can thus
be considered as representative of the state of patients on
PD. Patients labeled as new to dialysis likely correspond
to the patients reported in the USRDS report for the re-
spective years. In the 2002 USRDS Annual Data Report,
7447 patients were reported as starting PD in 1999 and
7372 patients in 2000 (USRDS ADR 2002, Table D-1).
These numbers correspond very closely to those in our
cohorts (Table 2) but may not be identical as the USRDS
reports 2168 patients for 1999 and 3015 in 2000 as “un-
certain dialysis,” (i.e., the nature of the dialysis modality
could not be determined from filed reports). Further, be-
cause only patients using Baxter PD systems are reported
in our database, it is likely that the numerical values in the
USRDS database represent an undercounting of patients
going on PD as their first dialysis modality. The propor-
tions of patients on APD reported in the 2002 USRDS
ADR for 1999 was 30.8% and 33.47% for 2000. These
aberrant results in the USRDS ADR are likely due to
inaccuracies in reporting of PD modality subtype within
that system. In our database, determination of PD sub-
modality is based on the actual presence of a cycler in
the patients’ homes, and hence is a definitive ascertain-
ment of submodality assignment. Our cohorts, therefore,
while numerically equivalent to the USRDS incident pa-
tients, have the advantage of better delineation of PD
submodality distribution. The proportion of diabetic pa-
tients in our cohorts also corresponds to the values re-
ported for all dialysis patients in the USRDS database:
44.5% in 1999, 45.2% in 2000, and 45.9% in 2001 (USRDS
ADR 2002, Table C-11). The current PD population in
the United States is thus characterized by a younger age
than the overall ESRD population, a similar prevalence
of diabetes mellitus, and a very high utilization of APD.
Our analysis also illustrates the large proportion of
patients starting PD within any particular year that are
transfers from chronic hemodialysis. This implies that any
point in time, a large proportion of patients on PD have
a history of HD treatment. This highlights the limitations
of outcome studies that look at prevalent populations and
do not consider the vintage of patients and preceding re-
nal replacement therapy. The overall characteristics of
patients transferred from HD to PD are not consonant
with the common assumptions of these patients being
older patients with severe comorbidities.
Studies in North American dialysis populations have
identified progressive improvements in outcomes over
the last decade. In the United States, these trends have
been more marked in patients on PD than those on HD.
Our findings extend these observations and suggest that
these trends in improvements in outcomes are continuing.
Because our data are more current than those reported
in the most recent USRDS ADR, the overall survival of
patients in our cohorts cannot be compared to the data
from the USRDS because for one-year survival, only
the 1999 cohort is available in the 2002 USRDS ADR.
The one-year survival of incident dialysis patient in 1999
in the USRDS ADR was 78.2% (USRDS ADR 2002,
Table I-22), and the two-year survival of incident patients
in 1998 was 63.2% (USRDS ADR 2002, Table I-24). Both
of these survival figures are lower than those observed in
the 1999 cohort of the present study: one-year survival of
83.12% and two-year survival of 69.94% (Table 3). This
is related to the fact that the USRDS survival rate re-
flects a summation of survival for all dialysis modalities
(HD and PD), and population studies have commonly
shown a survival advantage of PD in the first one to two
years of dialytic therapy [34–36]. Several studies have ex-
amined single-center as well as regional survival on PD
[16, 17, 22, 26, 28]. As indicated above, however, many of
the single-center studies spanned long periods of obser-
vation, during which time patient characteristics as well
as dialysis techniques were evolving, hence, the relevance
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of these studies to current discourse on modality effects is
limited, and little benefit would accrue from comparisons
with the cohorts in the present report.
Patient survival in the present study cohorts is not
very dissimilar from findings in Europe. The NECOSAD
trial observed a two-year patient survival of 77% [8], a
percentage higher than our overall two-year survival of
69.94%. However, a lower prevalence of diabetes melli-
tus was observed in the Netherlands Cooperative Study
on the Adequacy of Dialysis (NECOSAD) trial (16% to
20% vs. 45% in current study). Considering the impact
of diabetes on survival, it is likely that adjustment for
the proportion of diabetics in the two populations would
result in comparable outcomes (see Table 4).
In concordance with other studies, age and diabetes
mellitus were independent determinants of patient sur-
vival [5, 8, 34–37]. A novel observation in this study is the
impact of PD modality on patient survival. We observed
a higher survival rate for patients on APD versus patients
on CAPD. Several factors can be invoked to explain this
observation. Patients on APD tended to be younger than
patients on CAPD (Table 5), and while statistical adjust-
ment for age did not eliminate the difference, it is possible
for a residual effect of age to remain operative despite
the statistical adjustment. Another factor relates to the
characteristics of patients allocated to the different PD
modalities. It is possible, though difficult to explore in
the present database, that the type of patients allocated
to APD have certain characteristics that are favorable to
survival that are not adjusted for in our outcome analy-
sis. Patients with an active lifestyle may prefer APD for
the logistic advantages, and these patients may inherently
have a better survival that cosegregates with the choice
of APD submodality. Alternatively, it is possible that pa-
tients on APD have better compliance with therapy and
better ultrafiltration with the short cycler dwells and these
two factors may influence survival. This is clearly an area
that warrants additional future research. The prominent
findings of our analysis highlight the progressive improve-
ment of outcomes on PD in the United States that match,
after adjustment for differing comorbidities, outcomes in
Europe.
Secular trends in technique survival have been docu-
mented from population-wide registries. Schaubel et al
[3] examined the trends in technique survival in Canada
between 1981 and 1997. Technique failure rate ratios
(RR) estimated using Poisson regression and adjusted for
age, gender, race, province, primary renal diagnosis, and
follow-up time, were significantly reduced for the 1990 to
1993 (RR, 0.75; 95% CI, 0.68, 0.83), 1994 to 1995 (RR,
0.83; CI 0.75, 0.93), and 1996 to 1997 (RR, 0.78; CI 0.70,
0.87) calendar periods relative to 1981 to 1989 (RR, 1,
reference). Among cause-specific technique failure rates,
the greatest improvement was observed for peritonitis-
attributable technique failure, with RR, 0.46; CI 0.41, 0.50
for 1990 to 1997 relative to 1981 to 1989.
In the current study, we observed two temporal trends
of technique success: there were notable differences in
technique success across calendar years, particularly in
infection-related technique failure which declined over
time, a finding similar to that of Schaubel et al [3]. We also
observed a decline in technique failure between the first
and second year on therapy, which was most notable for
catheter malfunction and psychosocial causes. This find-
ing suggests that enhancement in catheter insertion tech-
niques, as well as focused psychosocial support, may be
crucial during the first year of PD. Further, both catheter
malfunction and psychosocial factors tended to be more
prominent as causes of technique failure in the first year
in patients on CAPD.
The effect of age on patient survival has been amply
documented. There have been, however, some contrary
information regarding the effect of age on technique suc-
cess. Beddhu et al [38] found in multivariate-adjusted
models each decade increase in age was associated with
an increased risk of technique failure (HR, 1.5; 95% CI,
1.0 to 2.3). Technique failure was inversely related to age
in an Italian study by Maiorca et al [25], while Huisman
et al [1] found that technique success declined with in-
creasing age. In the present study, age had no effect on
technique survival, suggesting that the modality can be
successful in any and all age groups. Diabetes mellitus
had a very marginal effect that appeared statistically sig-
nificant only because of the large size of the study popu-
lation, but is not likely to be clinically relevant, a finding
similar to that observed by Huisman et al [1]. One factor
that was dominant in affecting technique success was the
submodality of PD; patients on APD had a better tech-
nique success during the first year of dialysis compared
to patients on CAPD. This was due to a higher rate of
technique failure in CAPD during the first six months
on therapy due to catheter malfunction and psychosocial
causes.
The observation that center characteristics impacts pa-
tient and technique outcome was explored by Schaubel
et al [2] in the Canadian population. They observed that as
the cumulative number of PD patients treated increased,
covariate-adjusted mortality significantly decreased (P <
0.05); a weaker yet significant association was observed
between number of PD patients treated and technique
failure. As the percentage of patients initiating dialy-
sis on PD increased, technique failure rates decreased
significantly.
Using data from RENINE, the comprehensive dialy-
sis registry of the Netherlands, Huisman et al [1] ana-
lyzed PD technique failure rates in the period 1994 to
1999. Mean annual technique failure rates varied greatly
between centers (10% to 59%) and correlated with the
number of patients on PD in the center (r = −0.396, P =
0.009) and with the fraction of patients on PD (r =−0.410,
P = 0.006). Low technique survival rates occurred mainly
in centers with less than 20 patients on PD; relative risk
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Table 8. Transplant rate trends in the three study cohorts
Year 1999 2000 2001
Total
One year 5.5 4.7 4.9
Two year 9.1 8.9
Three year 8.1
New to dialysis
One year 5.8 5.1 5.4
Two year 9.6 9.5
Three year 8.8
Transfer from HD
One year 4.3 3.3 3.8
Two year 7.6 6.6
Three year 5.9
Failed transplant
One year 11 9.6 6.1
Two year 7.6 15.3
Three year 9.9
HD, hemodialysis.
for technique failure 1.68 as compared with larger centers.
Having fewer than 20 PD patients in a center or having a
small fraction of patients on PD carried an increased risk
of technique failure.
In the present study, center size was found to have
an effect on technique success and centers with fewer
than 20 patients on PD were found to have a lower tech-
nique success than centers with higher number. Unlike
Schaubel et al [2], we found no effect of center size on
patient survival, but like Huisman et al [1] and Schaubel
et al [2], center size in our analysis did affect technique
success rates. The results of all three studies (Canada [2],
the Netherlands [1], and the present report) imply that
a center’s experience with and degree of specialization
toward PD impact strongly on PD outcomes. One hy-
pothesis is that a center’s propensity to exploit techni-
cal and nontechnical advances in PD increases directly
with their experience. It is also possible that, through
experience, centers become more adept at identifying
appropriate patients to receive PD.
The USRDS gives two estimates of the patients re-
turning to dialysis because of a failed allograft: in 2000,
4166 patients returned to dialysis because of a failed allo-
graft by facility survey or 6800 patients returned to dialy-
sis by USRDS count (ADR 2002, Table 3.a). Whichever
the correct number, only a very small minority of these
patients returned to PD (Table 2). The outcome of pa-
tients starting PD after the failure of a renal graft has
been evaluated in a limited number of studies. Davies
et al [30] evaluated the clinical outcomes of patients
returning to PD with failing allografts and compared
those outcomes with outcomes in new, contemporary pa-
tients. The study identified 45 patients with failed allo-
grafts: 28 were commencing PD treatment, and 17 were
commencing HD treatment. Those patients were signifi-
cantly younger than the 469 new patients commencing PD
(P < 0.001). They saw no significant difference in the
survival of failed transplant patients commencing PD
compared with those commencing HD (log rank, P =
0.11). Kaplan-Meier plots of patient survival were bet-
ter for failed transplant patients compared with all
new PD patients. When corrected using Cox regres-
sion, the survival advantage was seen to be due to age
and comorbidity at start of PD. Pure technique fail-
ure (excluding death) was not different between the
groups.
The present study is the largest report to date of the
course of patients with failed allograft when they are
treated by PD. Our results suggest that these patients
have outcomes on PD that are better than patients new
to dialysis, despite a longer vintage with ESRD, and that
their first-year survival on PD is not too dissimilar from
that of patients newly transplanted [one-year patient sur-
vival for cadaveric transplant 94.4 (USRDS ADR 2002,
Table I-30)].
An evaluation of the USRDS database suggests that
transplant rates are higher in PD patients than HD
patients. In a Cox proportional hazards analysis that
was adjusted for multiple patient characteristics, kidney
transplantation was 1.39 (95% CI, 1.35 to 1.43) times
more likely in PD versus HD patients (P < 0.0001)
[39]. In a multivariate analysis applied to the combined
three inception cohorts in this study, older age, diabetes,
and female gender were all independently associated
with a lower transplantation rate. Studies in both the
United States [39] and Canada [40] have identified similar
patterns.
In summary, examination of contemporary cohorts of
patients on PD in the United States reveals a high level
of utilization of APD. Trends toward improved patient
survival, higher technique success, and increasing use of
cycler-based therapy with more recent calendar years
was noted. Age and diabetes were clear predictors of
patient survival, but did not appear to influence tech-
nique success. Technique success was higher in patients
on APD than in patients on CAPD, but this difference was
mostly concentrated in the first year on therapy. Patients
starting PD after a failed allograft had excellent survival
that approached during the first year patients receiving a
cadaveric allograft.
CONCLUSION
We conclude that the current state of PD in the United
States is characterized by improving patient outcomes,
higher technique success, and a predominance of use
of cycler-based therapy. Several opportunities amenable
to practice interventions for improving technique suc-
cess have been identified. The high success of PD in pa-
tients with failed allograft suggests that this modality can
be more frequently utilized in this group than current
practice.
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